Comprehensive Clinical Development, Inc. Report issue

For profit Phase 1
Founded: Miramar FL United States (1994)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2007
NCT00509743
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Comprehensive NeuroScience (CNS) | Comprehensive Phase One | Comprehensive Phase One, Miramar | Comprehensive Phase One Miramar, 3400 Enterprise Way, Miramar, FL 33025

Active Ingredients

Drugs in Phase 1 Trials (5)

artefenomel (1 trial)

bradanicline (1 trial)

cx157 (1 trial)

diclofenac (voltaren) (1 trial)

rti-336 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 1)

Cocaine-Related Disorders (Phase 1)

Depressive Disorder (Phase 1)

Depressive Disorder, Major (Phase 1)

Malaria (Phase 1)

Malaria, Falciparum (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 5
  • # of Trial APIs: 5